Showing results (41-50 of 53) with videos related to

Sort By:
Pageof 6
American Journal of Human Genetics|February 5, 2019
Erythroid-Progenitor-Targeted Gene Therapy Using Bifunctional TFR1 Ligand-Peptides in Human Erythropoietic ProtoporphyriaArienne Mirmiran, Caroline Schmitt, Thibaud Lefebvre, et al.
Human Molecular Genetics|January 24, 2018
From a dominant to an oligogenic model of inheritance with environmental modifiers in acute intermittent porphyriaHugo Lenglet, Caroline Schmitt, Thomas Grange, et al.
Nature Genetics|January 17, 2012
ABCB6 is dispensable for erythropoiesis and specifies the new blood group system LangereisVirginie Helias, Carole Saison, Bryan A Ballif, et al.
American Journal of Human Genetics|April 1, 2014
Antisense oligonucleotide-based therapy in human erythropoietic protoporphyriaVincent Oustric, Hana Manceau, Sarah Ducamp, et al.
Liver International : Official Journal of the International Association for the Study of the Liver|April 17, 2026
Clinical Characteristics and Outcomes of Acute Intermittent Porphyria: Insights From the European Porphyria RegistryCarl M Baravelli, Sverre Sandberg, Marte H Hammersland, et al.
Human Mutation|February 11, 2011
Sideroblastic anemia: molecular analysis of the ALAS2 gene in a series of 29 probands and functional studies of 10 missense mutationsSarah Ducamp, Caroline Kannengiesser, Mohamed Touati, et al.
American Journal of Human Genetics|September 2, 2008
C-terminal deletions in the ALAS2 gene lead to gain of function and cause X-linked dominant protoporphyria without anemia or iron overloadSharon D Whatley, Sarah Ducamp, Laurent Gouya, et al.
Genetics in Medicine : Official Journal of the American College of Medical Genetics|May 11, 2019
International Porphyria Molecular Diagnostic Collaborative: an evidence-based database of verified pathogenic and benign variants for the porphyriasBrenden Chen, Sharon Whatley, Michael Badminton, et al.
Pageof 6